The ATOPHIX brand, founded in 2000 (Switzerland), from 2951 sister brands and 17477 competing brands. ATOPHIX is owned by NOVARTIS N, listed on the stock exchange of Zurich The ISIN, the company's International Securities Identification Number, is CH0012005267. The sector of ATOPHIX is Drug Manufacturers.
Investment simulator :
Portfolio valuation
NOVARTIS N
(ATOPHIX)
over 5 years*
CHF 97.87